Tidal Trust II Defiance Daily Target 2X Long LLY ETFTidal Trust II Defiance Daily Target 2X Long LLY ETFTidal Trust II Defiance Daily Target 2X Long LLY ETF

Tidal Trust II Defiance Daily Target 2X Long LLY ETF

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪29.04 M‬USD
Fund flows (1Y)
‪31.78 M‬USD
Dividend yield (indicated)
Discount/Premium to NAV
0.03%
Shares outstanding
‪1.83 M‬
Expense ratio
1.29%

About Tidal Trust II Defiance Daily Target 2X Long LLY ETF


Issuer
Toroso Investments Topco LLC
Brand
Defiance
Inception date
Aug 7, 2024
Structure
Open-Ended Fund
Index tracked
No Underlying Index
Replication method
Synthetic
Management style
Active
Dividend treatment
Distributes
Distribution tax treatment
Ordinary income
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
Tidal Investments LLC
Distributor
Foreside Fund Services LLC
LLYX uses swap agreements to make bullish bets on Eli Lilly and Companys (NYSE: LLY) share price. LLY is a global pharmaceutical company dedicated to discovering, developing, manufacturing, and marketing innovative medicines in various therapeutic areas, including neuroscience, endocrinology, oncology, cardiovascular diseases, and immunology. The fund maintains a daily leveraged exposure equivalent to 200% of the funds net assets through daily rebalancing. As a geared product, the fund is intended as a short-term tactical tool, rather than as a long-term investment vehicle. As a result, returns may deviate from the expected 2x if held for longer than a single day due to compounding. This strategy is high-risk and does not include a defensive position as part of its overall process. Additionally, the fund could potentially lose money over time, even if LLY's performance strengthens. The fund is expected to invest in cash-like instruments as collateral.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharmaceuticals
Strategy
Vanilla
Geography
U.S.
Weighting scheme
Single asset
Selection criteria
Single asset

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of July 7, 2025
Exposure type
StocksBonds, Cash & Other
Cash
Stocks2.27%
Health Technology2.27%
Bonds, Cash & Other97.73%
Cash88.20%
Mutual fund9.53%
Stock breakdown by region
100%
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


LLYX assets under management is ‪29.04 M‬ USD. It's fallen 25.53% over the last month.
LLYX fund flows account for ‪31.78 M‬ USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, LLYX doesn't pay dividends to its holders.
LLYX shares are issued by Toroso Investments Topco LLC under the brand Defiance. The ETF was launched on Aug 7, 2024, and its management style is Active.
LLYX expense ratio is 1.29% meaning you'd have to pay 1.29% of your investment to help manage the fund.
LLYX follows the No Underlying Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
LLYX invests in cash.
LLYX price has risen by 0.71% over the last month, and its yearly performance shows a −33.42% decrease. See more dynamics on LLYX price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −0.54% over the last month, showed a 4.65% increase in three-month performance and has decreased by −13.42% in a year.
LLYX trades at a premium (0.31%) meaning the ETF is trading at a higher price than the calculated NAV.